VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1570172
Sex: F
Age: 51
State: MD

Vax Date: 03/20/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Hair Loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair Loss) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced ALOPECIA (Hair Loss). At the time of the report, ALOPECIA (Hair Loss) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570173
Sex: F
Age: 65
State: VT

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570174
Sex: F
Age: 67
State: SC

Vax Date: 03/03/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Tangling of the tongue; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISCOMFORT (Tangling of the tongue) and PAIN IN EXTREMITY (Sore Arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The patient's past medical history included Dental treatment NOS. Concomitant products included CALCIUM, VITAMIN D NOS, GLUCOSAMINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TONGUE DISCOMFORT (Tangling of the tongue) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, TONGUE DISCOMFORT (Tangling of the tongue) and PAIN IN EXTREMITY (Sore Arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: CALCIUM; VITAMIN D NOS; GLUCOSAMINE; MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1570175
Sex: M
Age: 78
State: MT

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Nausea; chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NAUSEA (Nausea) and CHILLS (chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The patient's past medical history included Dehydration, Pneumonia, Chest pain and Swelling of legs in December 2020. Concurrent medical conditions included Clot blood and Pericardial effusion since December 2020. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 10-Mar-2021, the patient experienced NAUSEA (Nausea) and CHILLS (chills). On 12-Mar-2021, NAUSEA (Nausea) and CHILLS (chills) had resolved. On 13-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness: Pericardial effusion

ID: 1570176
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Swelling on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling on the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling on the injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling on the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570177
Sex: M
Age: 75
State: TN

Vax Date: 02/12/2021
Onset Date: 03/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Injection site hot; Injection site itchy; Rash a at the injection site; Injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash a at the injection site) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash a at the injection site) and VACCINATION SITE ERYTHEMA (Injection site redness). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and ERGOCALCIFEROL, RETINOL (A&D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash a at the injection site) and VACCINATION SITE ERYTHEMA (Injection site redness) had not resolved. About 4-5 days after the second dose, the patient developed a rash a at the injection site, which was red, a circle about 3-4 inches, hot and itchy. No concomitant medication was given. Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow-up received on 09-May-2021 and does not contain any new information.

Other Meds:

Current Illness:

ID: 1570178
Sex: M
Age: 62
State: TX

Vax Date: 03/21/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: feels like the flu symptom; tired; fever; headache; body ache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like the flu symptom), FATIGUE (tired), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like the flu symptom), FATIGUE (tired), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache). At the time of the report, INFLUENZA LIKE ILLNESS (feels like the flu symptom), FATIGUE (tired), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information, if any, was not provided.

Other Meds:

Current Illness:

ID: 1570179
Sex: F
Age: 83
State: SC

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: High blood pressure; drugged sleep, very deep than her normal sleeps; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure) and SLEEP DISORDER (drugged sleep, very deep than her normal sleeps) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. Concurrent medical conditions included Allergic reaction to drug and Blood pressure abnormal. Concomitant products included ALPRAZOLAM for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (High blood pressure) and SLEEP DISORDER (drugged sleep, very deep than her normal sleeps). At the time of the report, HYPERTENSION (High blood pressure) and SLEEP DISORDER (drugged sleep, very deep than her normal sleeps) had resolved. Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: significant follow up received on 23 JUL 2021, new event (sleep disorder) added, event outcome for high blood pressure updated,second dose information was added

Other Meds: ALPRAZOLAM

Current Illness: Allergic reaction to drug; Blood pressure abnormal

ID: 1570180
Sex: F
Age: 76
State: MT

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Nausea; chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NAUSEA (Nausea) and CHILLS (chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 10-Mar-2021, the patient experienced NAUSEA (Nausea) and CHILLS (chills). On 10-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 12-Mar-2021, NAUSEA (Nausea) and CHILLS (chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570181
Sex: F
Age: 68
State: WI

Vax Date: 03/19/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: This spontaneous case was reported by an other and describes the occurrence of ASTHENIA (weak), FATIGUE (fatigue), MYALGIA (couldn't get out of bed with body aches) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weak), FATIGUE (fatigue), MYALGIA (couldn't get out of bed with body aches) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (weak), FATIGUE (fatigue), MYALGIA (couldn't get out of bed with body aches) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24/05/2021 Contains No New Significant Information. Patient denied further follow up.

Other Meds:

Current Illness:

ID: 1570182
Sex: F
Age: 46
State: OH

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: could not get the second dose, got the flu, and now she is going to get 2 months after; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not get the second dose, got the flu, and now she is going to get 2 months after) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not get the second dose, got the flu, and now she is going to get 2 months after). On 12-Jan-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not get the second dose, got the flu, and now she is going to get 2 months after) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications or treatment details reported.

Other Meds:

Current Illness:

ID: 1570183
Sex: F
Age:
State: CA

Vax Date: 03/13/2021
Onset Date: 03/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Bumps; Another attack of hives; hives all over my body; Body is itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over my body), PRURITUS (Body is itching), NODULE (Bumps) and URTICARIA (Another attack of hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced URTICARIA (hives all over my body) and PRURITUS (Body is itching). On 20-Mar-2021, the patient experienced URTICARIA (Another attack of hives). On an unknown date, the patient experienced NODULE (Bumps). On 16-Mar-2021, PRURITUS (Body is itching) had resolved. At the time of the report, URTICARIA (hives all over my body) outcome was unknown and NODULE (Bumps) and URTICARIA (Another attack of hives) had not resolved. Concomitant product use was not provided by the reporter. No treatment information was provided. The action taken with mRNA-1273 with the events was considered as not applicable For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1570184
Sex: F
Age:
State: NH

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: felt tingling in her feet and hands; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. Concurrent medical conditions included Contrast media allergy (severe allergic reaction to contrast dye). Concomitant products included HCTZ for an unknown indication. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). The patient was treated with WATER at an unspecified dose and frequency; DIAZEPAM at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (felt tingling in her feet and hands), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Blood pressure measurement: >200 (Inconclusive) BP was >200. On 20-Mar-2021, Heart rate: 115 (Inconclusive) HR was 115. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included fluids, OJ.

Other Meds: HCTZ

Current Illness: Contrast media allergy (severe allergic reaction to contrast dye)

ID: 1570185
Sex: F
Age: 65
State: OH

Vax Date: 03/05/2021
Onset Date: 03/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: headache; like she hit a wall.; her hand it hurts; joint paint in her R hand; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts), ARTHRALGIA (joint paint in her R hand) and HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts) and ARTHRALGIA (joint paint in her R hand). On 22-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts) and ARTHRALGIA (joint paint in her R hand) outcome was unknown and HEADACHE (headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. . Concomitant medications reported were to treat high blood pressure.

Other Meds:

Current Illness: Blood pressure high

ID: 1570186
Sex: F
Age:
State: MA

Vax Date: 02/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: flu like symptoms; Loss of Appetite; headache; achy; Extreme Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache), MYALGIA (achy) and FATIGUE (Extreme Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. Concurrent medical conditions included Hypertension. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache) and FATIGUE (Extreme Fatigue). 04-Mar-2021, the patient experienced MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache), MYALGIA (achy) and FATIGUE (Extreme Fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: high (High) elevated temperature. In concomitant medications high blood pressure medications were reported. This case was linked to MOD-2021-052953 (Patient Link).

Other Meds:

Current Illness: Hypertension

ID: 1570187
Sex: F
Age:
State: MI

Vax Date: 02/20/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: was dizzy; missed her appointment; soreness of arm; nauseous; threw up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (was dizzy), PRODUCT DOSE OMISSION ISSUE (missed her appointment), PAIN IN EXTREMITY (soreness of arm), NAUSEA (nauseous) and VOMITING (threw up) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concomitant products included INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN 70/30), CARVEDILOL, METOLAZONE, TORSEMIDE, PRAVASTATIN and POTASSIUM CHLORIDE for an unknown indication. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (was dizzy), PRODUCT DOSE OMISSION ISSUE (missed her appointment), PAIN IN EXTREMITY (soreness of arm), NAUSEA (nauseous) and VOMITING (threw up). On 18-Mar-2021, PRODUCT DOSE OMISSION ISSUE (missed her appointment) had resolved. At the time of the report, DIZZINESS (was dizzy), PAIN IN EXTREMITY (soreness of arm), NAUSEA (nauseous) and VOMITING (threw up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment details reported.

Other Meds: NOVOLIN 70/30; CARVEDILOL; METOLAZONE; TORSEMIDE; PRAVASTATIN; POTASSIUM CHLORIDE

Current Illness:

ID: 1570188
Sex: F
Age: 80
State: WA

Vax Date: 02/13/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Received the 2nd Moderna vaccine on 27Feb2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd Moderna vaccine on 27Feb2021) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No recorded medical history). On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd Moderna vaccine on 27Feb2021). On 27-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd Moderna vaccine on 27Feb2021) had resolved. Not Related No concomitant or treatment medications were reported.; Reporter's Comments: This report refers to a case of Inappropriate schedule of product administration, for mRNA-1273, lot # Unkonwn, with no associated AEs.

Other Meds:

Current Illness:

ID: 1570189
Sex: M
Age: 62
State:

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Arm was swollen from elbow to shoulder; Arm was red; Arm was hot; Arm aches so bad he can die; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen from elbow to shoulder), ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and PAIN IN EXTREMITY (Arm aches so bad he can die) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003b21a) for COVID-19 vaccination. The patient's past medical history included Bone injury (trapezoid injury) on 16-Mar-2021. Concurrent medical conditions included Blood pressure high and Cholesterol. On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen from elbow to shoulder), ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and PAIN IN EXTREMITY (Arm aches so bad he can die). At the time of the report, PERIPHERAL SWELLING (Arm was swollen from elbow to shoulder), ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and PAIN IN EXTREMITY (Arm aches so bad he can die) outcome was unknown.

Other Meds:

Current Illness: Blood pressure high; Cholesterol

ID: 1570190
Sex: F
Age:
State: MD

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: haven't received 2nd dose; fast heartbeat of over 200/pulse high; dizziness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heartbeat of over 200/pulse high), DIZZINESS (dizziness), PRODUCT DOSE OMISSION ISSUE (haven't received 2nd dose) and ARTHRALGIA (joint pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: flu vaccine. Past adverse reactions to the above products included No adverse reaction with flu vaccine. Concurrent medical conditions included Drug allergy (Citalopram), Drug allergy (Ciprofloxacin), Drug allergy (Metilprednisone), Anxiety and Heart rate increased (The patient sometimes get fast heartbeat but it did not long as long as it lasted after administration of Covid-19 vaccine). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D3 for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ARTHRALGIA (joint pain). On 27-Feb-2021, the patient experienced DIZZINESS (dizziness). On 01-Mar-2021, the patient experienced PALPITATIONS (fast heartbeat of over 200/pulse high). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (haven't received 2nd dose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PALPITATIONS (fast heartbeat of over 200/pulse high), DIZZINESS (dizziness) and ARTHRALGIA (joint pain) was resolving and PRODUCT DOSE OMISSION ISSUE (haven't received 2nd dose) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Heart rate: 200 (High) Fast heartbeat. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. No treatment details provided. Reported that patient hasn't gotten the second dose of vaccine. Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Reporter's city, New event added. On 08-Jun-2021: Reporter's email address and event verbatim of Missed dose updated.

Other Meds: SYNTHROID; VITAMIN D3

Current Illness: Anxiety; Drug allergy (Metilprednisone); Drug allergy (Citalopram); Drug allergy (Ciprofloxacin); Heart rate increased (The patient sometimes get fast heartbeat but it did not long as long as it lasted after administration of Covid-19 vaccine)

ID: 1570191
Sex: M
Age:
State: FL

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: swollen thyroid; difficulty breathing; swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes), GOITRE (swollen thyroid) and DYSPNOEA (difficulty breathing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes), GOITRE (swollen thyroid) and DYSPNOEA (difficulty breathing). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes), GOITRE (swollen thyroid) and DYSPNOEA (difficulty breathing) outcome was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1570192
Sex: F
Age: 16
State: NC

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Patient under 18 years of age had Moderna vaccine; A spontaneous report was received from a consumer concerning a 16-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) resulting in the event, patient under 18 years of age had Moderna vaccine/ product administered to patient of inappropriate age. The patient's medical history was not provided. No relevant concomitant medications were reported. On 17 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 026a21a) intramuscularly for prophylaxis of COVID-19 infection. On 17 Mar 2021, the Moderna COVID vaccine was given to a 16- year old patient. No adverse event was reported by the patient after being given the vaccine. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the event, product administered to patient of inappropriate age, was considered resolved on 17 Mar 2021.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number 026A21A) with no associated AEs reported.

Other Meds:

Current Illness:

ID: 1570193
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 03/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: sore arm; didn't have any energy; head hurt; nauseous; achy all over; low blood sugar; very dizzy; could hardly stand up; temperature was 99.8?F; weak; didn't felt too much like eating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), EATING DISORDER (didn't felt too much like eating), HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy) and DYSSTASIA (could hardly stand up) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced EATING DISORDER (didn't felt too much like eating). On 16-Mar-2021, the patient experienced HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy), DYSSTASIA (could hardly stand up), BODY TEMPERATURE INCREASED (temperature was 99.8?F), ASTHENIA (weak), HEAD DISCOMFORT (head hurt), NAUSEA (nauseous) and MYALGIA (achy all over). On 17-Mar-2021, the patient experienced ASTHENIA (didn't have any energy). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 15-Mar-2021, EATING DISORDER (didn't felt too much like eating) had resolved. On 16-Mar-2021, HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy), DYSSTASIA (could hardly stand up), BODY TEMPERATURE INCREASED (temperature was 99.8?F), ASTHENIA (weak), HEAD DISCOMFORT (head hurt), NAUSEA (nauseous) and MYALGIA (achy all over) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and ASTHENIA (didn't have any energy) outcome was unknown. Concomitant meds: unknown blood pressure medicine and unknown diabetes medication. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1570194
Sex: M
Age:
State: NC

Vax Date: 02/13/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: started walking funny/cannot walk properly/cannot walk unless he has a cane; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (started walking funny/cannot walk properly/cannot walk unless he has a cane) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21 and 024M20A) for COVID-19 vaccination. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), OMEPRAZOLE and PANTOPRAZOLE for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced GAIT DISTURBANCE (started walking funny/cannot walk properly/cannot walk unless he has a cane). At the time of the report, GAIT DISTURBANCE (started walking funny/cannot walk properly/cannot walk unless he has a cane) outcome was unknown. Action taken with mRNA-1273 in response to the events was not applicable Concomitant medications includes Bromphen/pseudo/dextro HBR syrup No treatment medications provided

Other Meds: ZYRTEC ALLERGY; OMEPRAZOLE; PANTOPRAZOLE

Current Illness:

ID: 1570195
Sex: F
Age:
State: MA

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Inappropriate age for Vaccine Administration; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications include high blood pressure medications. Treatment details included Tylenol. This case was linked to MOD-2021-052934 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up email added, Patient age updated, Inappropriate age for Vaccine Administration

Other Meds:

Current Illness: Blood pressure high

ID: 1570196
Sex: M
Age: 72
State: NY

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS POSTURAL (dizzy when he stand up), FATIGUE (fatigue) and NAUSEA (nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012120A and 010M20A) for COVID-19 vaccination. Concomitant products included AMLODIPINE, LOSARTAN and METFORMIN for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS POSTURAL (dizzy when he stand up), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, DIZZINESS POSTURAL (dizzy when he stand up), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds: AMLODIPINE; LOSARTAN; METFORMIN

Current Illness:

ID: 1570197
Sex: F
Age: 51
State:

Vax Date: 03/21/2021
Onset Date: 03/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: she has not taken 2nd dose; Feeling really sick; chest hurts; Nausea; body ache; Arm started hurting; no energy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), ILLNESS (Feeling really sick), CHEST PAIN (chest hurts) and NAUSEA (Nausea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04GA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), NAUSEA (Nausea) and MYALGIA (body ache). On 22-Mar-2021, the patient experienced ILLNESS (Feeling really sick) and CHEST PAIN (chest hurts). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (she has not taken 2nd dose). At the time of the report, PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), ILLNESS (Feeling really sick), CHEST PAIN (chest hurts), NAUSEA (Nausea), MYALGIA (body ache) and PRODUCT DOSE OMISSION ISSUE (she has not taken 2nd dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. Treatment information were reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: TCR

Other Meds:

Current Illness:

ID: 1570198
Sex: M
Age: 64
State: MA

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Stuffy nose; Stomachache; Chills; Headache; Body aches; Joint pains; fever; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body aches) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (He tested Positive for Covid in Feb2021) in February 2021. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Body aches), ARTHRALGIA (Joint pains) and PYREXIA (fever). At the time of the report, NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Body aches), ARTHRALGIA (Joint pains) and PYREXIA (fever) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, COVID-19: positive (Positive) Positive in Feb-2021. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported No treatment drugs were reported Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received :Event outcome updated and declined to further follow-up

Other Meds:

Current Illness:

ID: 1570199
Sex: F
Age:
State: NV

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen arm around the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen arm around the injection site). At the time of the report, VACCINATION SITE SWELLING (swollen arm around the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1570200
Sex: M
Age:
State: DE

Vax Date: 02/12/2021
Onset Date: 03/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Bumps and dots on stomach; Redness on stomach; Itchiness on both arms; Bumps on both arms; Redness on both arms; Sweating profusely; Itchiness on back; Bumps and dots on back; Redness on back; Itchiness on stomach; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 22-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness on back), KERATOSIS PILARIS (Bumps and dots on back), ERYTHEMA (Redness on back), PRURITUS (Itchiness on stomach) and KERATOSIS PILARIS (Bumps and dots on stomach) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (Codeine) and Blood pressure high. Concomitant products included CANDESARTAN for Blood pressure high. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced PRURITUS (Itchiness on back), KERATOSIS PILARIS (Bumps and dots on back), ERYTHEMA (Redness on back) and PRURITUS (Itchiness on stomach). On an unknown date, the patient experienced KERATOSIS PILARIS (Bumps and dots on stomach), ERYTHEMA (Redness on stomach), PRURITUS (Itchiness on both arms), KERATOSIS PILARIS (Bumps on both arms), ERYTHEMA (Redness on both arms) and HYPERHIDROSIS (Sweating profusely). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchiness on back), KERATOSIS PILARIS (Bumps and dots on back), ERYTHEMA (Redness on back), PRURITUS (Itchiness on stomach), KERATOSIS PILARIS (Bumps and dots on stomach), ERYTHEMA (Redness on stomach), PRURITUS (Itchiness on both arms), KERATOSIS PILARIS (Bumps on both arms), ERYTHEMA (Redness on both arms) and HYPERHIDROSIS (Sweating profusely) outcome was unknown. Not Provided Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: ADR form

Other Meds: CANDESARTAN

Current Illness: Blood pressure high; Drug allergy (Codeine)

ID: 1570201
Sex: F
Age:
State: CA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: 17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error). On 19-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570202
Sex: F
Age: 41
State: TX

Vax Date: 12/29/2020
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Received 2nd shot of Vaccine after 7 weeks of 1st dose; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 25-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose). On 25-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Concomitant medications not provided Treatment information not provided; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Not Provided) with no associated AEs.

Other Meds:

Current Illness:

ID: 1570203
Sex: F
Age: 67
State: CO

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Pain; Arm hurts; Soar arm; Knee hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), PAIN IN EXTREMITY (Arm hurts), MYALGIA (Soar arm) and ARTHRALGIA (Knee hurts) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. Concurrent medical conditions included Rheumatoid arthritis and Diabetes. Concomitant products included OXYGEN for an unknown indication. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN (Pain), PAIN IN EXTREMITY (Arm hurts), MYALGIA (Soar arm) and ARTHRALGIA (Knee hurts). At the time of the report, PAIN (Pain), PAIN IN EXTREMITY (Arm hurts), MYALGIA (Soar arm) and ARTHRALGIA (Knee hurts) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Other concomitant medications included rheumatoid arthritis and diabetic medications. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: No new information was updated.

Other Meds: OXYGEN

Current Illness: Diabetes; Rheumatoid arthritis

ID: 1570204
Sex: F
Age: 73
State: FL

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Got very sick; Itchy at injection site; Arm swelling at the injection site; Hard knot at the injection site; Red at injection site; Threw up twice; Very bad chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site) and VACCINATION SITE ERYTHEMA (Red at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. A44821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VOMITING (Threw up twice) and CHILLS (Very bad chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VOMITING (Threw up twice) and CHILLS (Very bad chills) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1570205
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Cannot get dose within the recommended time period; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Cannot get dose within the recommended time period) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Cannot get dose within the recommended time period). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Cannot get dose within the recommended time period) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication information not provided. Treatment information not provided.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown, with no associated AEs.

Other Meds:

Current Illness:

ID: 1570206
Sex: F
Age: 59
State: NC

Vax Date: 03/12/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: warm area where vaccine was given; knot where vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. No medical history information were provided by the reporter. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given). At the time of the report, VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information were not provided by the reporter.. Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021

Other Meds:

Current Illness:

ID: 1570207
Sex: F
Age:
State: UT

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: sick for five days; fast heartbeat; dizziness; read and bruised arm; muscle pain; chills; nausea; headache; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat), ILLNESS (sick for five days) and CONTUSION (read and bruised arm). At the time of the report, MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat), ILLNESS (sick for five days) and CONTUSION (read and bruised arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant and treatment medications were provided.

Other Meds:

Current Illness:

ID: 1570208
Sex: F
Age:
State: NY

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: rash on arm; fever (101); Nausea; I experienced new loss of smell; dizziness; really bad fogginess; unable to woke up in the morning; loss of taste sensation; Headache; chills; severe joint pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning) and AGEUSIA (loss of taste sensation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue), PYREXIA (fever (101)) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced RASH (rash on arm). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. On 17-Mar-2021, ANOSMIA (I experienced new loss of smell), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue) and PYREXIA (fever (101)) had resolved. At the time of the report, DIZZINESS (dizziness) and NAUSEA (Nausea) had not resolved and RASH (rash on arm) outcome was unknown. Action taken with mRNA-1273 in response to the events was not applicable. Treatment included Tylenol

Other Meds:

Current Illness:

ID: 1570209
Sex: F
Age: 71
State: TX

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: red spot the size of a quarter at the injection site; hardness at the injection site; a minor lump at the injection site; injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (red spot the size of a quarter at the injection site), VACCINATION SITE DISCOMFORT (hardness at the injection site), VACCINATION SITE MASS (a minor lump at the injection site) and INJECTION SITE PRURITUS (injection site itching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A01A) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE BRUISING (red spot the size of a quarter at the injection site), VACCINATION SITE DISCOMFORT (hardness at the injection site), VACCINATION SITE MASS (a minor lump at the injection site) and INJECTION SITE PRURITUS (injection site itching). At the time of the report, VACCINATION SITE BRUISING (red spot the size of a quarter at the injection site), VACCINATION SITE DISCOMFORT (hardness at the injection site), VACCINATION SITE MASS (a minor lump at the injection site) and INJECTION SITE PRURITUS (injection site itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: NNI

Other Meds:

Current Illness:

ID: 1570210
Sex: F
Age: 89
State: NY

Vax Date: 03/03/2021
Onset Date: 03/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Delayed adverse events; Not feeling well; Fever of 102degrees; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Delayed adverse events), ILLNESS (Not feeling well), PYREXIA (Fever of 102degrees) and FATIGUE (Felt tired) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced ADVERSE REACTION (Delayed adverse events), ILLNESS (Not feeling well), PYREXIA (Fever of 102degrees) and FATIGUE (Felt tired). On 16-Mar-2021, ADVERSE REACTION (Delayed adverse events), ILLNESS (Not feeling well), PYREXIA (Fever of 102degrees) and FATIGUE (Felt tired) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 102 (High) 102 degree. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD21-059464 (Patient Link).

Other Meds:

Current Illness:

ID: 1570211
Sex: F
Age: 67
State: NY

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of MOUTH ULCERATION (developed ulcers in her mouth) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced MOUTH ULCERATION (developed ulcers in her mouth). At the time of the report, MOUTH ULCERATION (developed ulcers in her mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided. Treatment for the included Benadryl and a swishing solution.

Other Meds:

Current Illness:

ID: 1570212
Sex: F
Age:
State: MD

Vax Date:
Onset Date: 03/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Headache; This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (Headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1570213
Sex: F
Age: 75
State: NJ

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: fast heartbeat; high blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heartbeat) and HYPERTENSION (high blood pressure) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PALPITATIONS (fast heartbeat) and HYPERTENSION (high blood pressure). On 11-Mar-2021, PALPITATIONS (fast heartbeat) and HYPERTENSION (high blood pressure) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Blood pressure measurement: high (High) High. On 11-Mar-2021, Heart rate: fast (High) Fast. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant and treatment information not provided

Other Meds:

Current Illness:

ID: 1570214
Sex: F
Age:
State: MI

Vax Date: 02/24/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: headache; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (headache), NAUSEA (Nausea) and VOMITING (Vomiting). On 05-Mar-2021, HEADACHE (headache), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant and treatment information not provided

Other Meds:

Current Illness:

ID: 1570215
Sex: F
Age:
State: NY

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), MUSCLE SPASMS (cramping), FLATULENCE (gas) and ABDOMINAL PAIN UPPER (stomach ache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010821A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), MUSCLE SPASMS (cramping), FLATULENCE (gas) and ABDOMINAL PAIN UPPER (stomach ache). At the time of the report, ABDOMINAL PAIN (abdominal pain), MUSCLE SPASMS (cramping), FLATULENCE (gas) and ABDOMINAL PAIN UPPER (stomach ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-116440.

Other Meds:

Current Illness:

ID: 1570216
Sex: F
Age: 54
State: MS

Vax Date: 03/12/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Warm to touch at the injection site; Hard spot at the injection site; Slight itching at the injection site; Red spot at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 22-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE INDURATION (Hard spot at the injection site), VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (Red spot at the injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE INDURATION (Hard spot at the injection site), VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (Red spot at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE INDURATION (Hard spot at the injection site), VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (Red spot at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided Treatment information was not provided

Other Meds:

Current Illness:

ID: 1570217
Sex: M
Age:
State: CA

Vax Date: 02/13/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Impingement syndrome of the left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ROTATOR CUFF SYNDROME (Impingement syndrome of the left shoulder) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A2/Z1A and 007M(2/Z)0A) for COVID-19 vaccination. Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) from 21-Mar-2021 to 21-Mar-2021 for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ROTATOR CUFF SYNDROME (Impingement syndrome of the left shoulder). At the time of the report, ROTATOR CUFF SYNDROME (Impingement syndrome of the left shoulder) outcome was unknown. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up information received updated event information.

Other Meds: TDAP

Current Illness:

ID: 1570218
Sex: F
Age: 64
State: GA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Tennis ball sized lump (not circular) at the injection site; Sore to touch at the injection site; Red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Tennis ball sized lump (not circular) at the injection site), VACCINATION SITE PAIN (Sore to touch at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE MASS (Tennis ball sized lump (not circular) at the injection site), VACCINATION SITE PAIN (Sore to touch at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site). At the time of the report, VACCINATION SITE MASS (Tennis ball sized lump (not circular) at the injection site), VACCINATION SITE PAIN (Sore to touch at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product information was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1570219
Sex: F
Age: 58
State: AZ

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her both arms and both legs) and VACCINATION SITE RASH (Rash at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On 10-Mar-2021, the patient experienced RASH (Rash on her both arms and both legs). On 01-Mar-2021, VACCINATION SITE RASH (Rash at injection site) had resolved. At the time of the report, RASH (Rash on her both arms and both legs) outcome was unknown. Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medications were reported. Treatment information was unknown. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Updated action taken, re-challenge .

Other Meds:

Current Illness:

ID: 1570220
Sex: M
Age: 69
State: FL

Vax Date: 03/11/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Gastrointestinal issues; Anxiety; Face movements; Nose tingling on the left side; Mouth tingling on the left side; He feels like his muscles move on the inside; Migraine; Vomiting; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side) and PARAESTHESIA ORAL (Mouth tingling on the left side) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) for Glaucoma, LEVOTHYROXINE for an unknown indication. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side), PARAESTHESIA ORAL (Mouth tingling on the left side), MUSCLE DISCOMFORT (He feels like his muscles move on the inside), MIGRAINE (Migraine), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side), PARAESTHESIA ORAL (Mouth tingling on the left side), MUSCLE DISCOMFORT (He feels like his muscles move on the inside), MIGRAINE (Migraine), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Went to ER and was treated for migraine and GI with injections and also Tylenol

Other Meds: LEVOTHYROXINE; EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]

Current Illness:

ID: 1570221
Sex: F
Age: 65
State: KY

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Loss of appetite; arm pain; Fatigue; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm pain), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. Concomitant products included DILTIAZEM, ESCITALOPRAM, ATORVASTATIN, CHONDROITIN SULFATE SODIUM, GLUCOSAMINE SULFATE POTASSIUM CHLORIDE (GLUCOSAMINE + CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE SULFATE POTASSIUM CHLORIDE]), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN C [ASCORBIC ACID] and FISH OIL. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm pain), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache). On 09-Mar-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. treatment information not provided.

Other Meds: DILTIAZEM; ESCITALOPRAM; ATORVASTATIN; GLUCOSAMINE + CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE SULFATE POTASSIUM CHLORIDE]; VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN C [ASCORBIC ACID]; FISH OIL

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm